Phase I Study of MEDI3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined With Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid Tumors
Hyman, David M., Rizvi, Naiyer A., Natale, Ronald B., Armstrong, Deborah K., Birrer, Michael J, Recht, Lawrence, Dotan, Efrat, Makker, Vicky, Kaley, Thomas J, Kuruvilla, Denison, Gribbin, Matthew, McDLanguage:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-17-1775
Date:
March, 2018
File:
PDF, 653 KB
english, 2018